Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:The lysosome–cathepsin axis in pancreatic cancer : mechanisms of stromal remodeling, immune evasion, and therapy resistance
Authors:ID Mazej Jeram, Nika, Institut "Jožef Stefan" (Author)
ID Senjor, Emanuela, Institut "Jožef Stefan" (Author)
ID Kos, Janko, Institut "Jožef Stefan" (Author)
ID Perišić, Milica, Institut "Jožef Stefan" (Author)
Files:URL URL - Source URL, visit https://www.mdpi.com/2218-273X/16/6/824
 
.pdf PDF - Presentation file, download (1,92 MB)
MD5: 54C99CCCF8787CC4098F81A5B9CB73F9
 
Language:English
Typology:1.02 - Review Article
Organization:Logo IJS - Jožef Stefan Institute
Abstract:Pancreatic cancer remains one of the most lethal malignancies worldwide, with pancreatic ductal adenocarcinoma accounting for the vast majority of cases and characterized by extensive desmoplasia, immune exclusion, and resistance to systemic therapies. Increasing evidence implicates lysosomal cathepsins as important regulators of these defining features of pancreatic tumor biology. Cathepsin-dependent proteolysis and lysosome-associated signaling pathways contribute to extracellular matrix remodeling, regulate immune cell trafficking, and influence antigen processing and presentation. Beyond their classical degradative functions, cathepsins participate in stress-adaptive cellular programs linked to autophagy, metabolic regulation, and proteostasis, supporting tumor cell survival under hypoxic, nutrient-limited, and therapy-induced stress conditions. Within the tumor microenvironment, dysregulated cathepsin activity promotes immune evasion by reshaping cytokine networks, impairing effective antigen presentation, and reinforcing physical and functional barriers to cytotoxic T-cell infiltration. Collectively, these mechanisms position the lysosome–cathepsin system as a central regulator of proteolytic remodeling, immune exclusion, and adaptive therapy resistance in pancreatic cancer, highlighting its potential relevance for emerging combinatorial therapeutic strategies.
Keywords:tumor microenvironment, autophagy, therapeutic resistance, immune evasion, extracellular matrix remodelling, cytotoxic cells, antigen presentation, lysosome
Publication status:Published
Publication version:Version of Record
Submitted for review:22.04.2026
Article acceptance date:27.05.2026
Publication date:02.06.2026
Publisher:MDPI
Year of publishing:2026
Number of pages:str. 1-40
Numbering:Vol. 16, iss. 6, [art. no.] 824
Source:Švica
PID:20.500.12556/DiRROS-29780 New window
UDC:577
ISSN on article:2218-273X
DOI:10.3390/biom16060824 New window
COBISS.SI-ID:280443139 New window
Copyright:© 2026 by the authors.
Note:Nasl. z nasl. zaslona; Soavtorji: Emanuela Senjor, Janko Kos, Milica Perišić Nanut; Opis vira z dne 4. 6. 2026;
Publication date in DiRROS:05.06.2026
Views:89
Downloads:67
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Biomolecules
Shortened title:Biomolecules
Publisher:MDPI AG
ISSN:2218-273X
COBISS.SI-ID:519952921 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0127-2019
Name:Farmacevtska biotehnologija: znanost za zdravje

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:Z3-50102-2023
Name:NK celična terapija glioblastoma: Modulacija cistatina F za izboljšanje učinkovitosti terapije

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-60067-2025
Name:Izboljšanje imunoterapije raka slinavke z zaviranjem katepsinov

Funder:Other - Other funder or multiple funders
Project number:RSF-0041
Name:RSF Pillar “SCIENCE"

Funder:International Centre for Genetic Engineering and Biology
Project number:CRP/SVN24-01
Name:LET (‘s) IMPACT

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:02.06.2026
Applies to:VoR

Secondary language

Language:Slovenian
Title:The lysosome–cathepsin axis in pancreatic cancer: mechanisms of stromal remodeling, immune evasion, and therapy resistance
Keywords:tumorsko mikrookolje, avtofagija, citotoksične celice, lizosom


Back